Brian Larkin
CIK 1563600 · View on SEC EDGAR ↗
First SEC filing: Dec. 10, 2012 · Latest: Dec. 10, 2012
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 8, 2014 | IART | S | 1,947 | $48.28 | $94,001 | 7,069 Direct | -21.59% | Disposed | -24.9% (price as of 2026-08-19) |
| Feb. 27, 2014 | IART | S | 3,265 | $46.15 | $150,680 | 10,256 Direct | -24.15% | Disposed | -21.4% (price as of 2026-08-19) |
| Aug. 19, 2013 | IART | S | 7,490 | $41.90 | $313,831 | 13,521 Direct | -35.65% | Disposed | -13.4% (price as of 2026-08-19) |
| May 21, 2013 | IART | S | 200 | $36.86 | $7,372 | 21,498 Direct | -0.92% | Disposed | -1.6% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 10, 2012 | IART | Common Stock | 20,978 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
IART
President — Global Spine & Orthobiologics & Head of Strategic Development (20)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2013 | $336,615 | — | — | — | — | — | $4,125 | $470,815 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.